Dr. Li Xiaofeng

Chief Physician; Professor; Director of Rheumatology Department; Distinguished Expert of Shanxi Province

Built the rheumatology department at Second Hospital of Shanxi Medical University into a nationally recognized center for rheumatoid arthritis treatment; pioneered the adoption and optimization of biologic therapies (TNF inhibitors, IL-6 inhibitors, JAK inhibitors) for RA in northern China; led multi-center clinical trials on novel biologic agents; contributed to CRDC data collection and Chinese RA treatment guidelines; published in Annals of the Rheumatic Diseases, Chinese Medical Journal, and International Immunopharmacology

Dr. Li offers deep expertise in biologic therapy selection and management for rheumatoid arthritis. Patients from northern China and those seeking specialized RA management outside the traditional Beijing/Shanghai axis will find his center well-equipped with modern infusion facilities and experienced nursing staff.

Research this doctor's background on trusted platforms.

Results are automated searches and may include other individuals with similar names.